Koers Avacta Group Plc London S.E.
Aandelen
GB0033519546
Biotechnologie & Medisch Onderzoek
slotkoers
Andere beurzen
|
||
- GBX | - |
Omzet 2023 | 23,25 mln. 29,68 mln. 27,33 mln. | Omzet 2024 * | 24,5 mln. 31,28 mln. 28,8 mln. | Marktkapitalisatie | 151 mln. 192 mln. 177 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2023 | -24 mln. -30,64 mln. -28,22 mln. | Nettowinst (verlies) 2024 * | -27 mln. -34,47 mln. -31,74 mln. | EV/omzet 2023 | 14 x |
Nettoliquiditeiten 2023 * | 16,2 mln. 20,68 mln. 19,05 mln. | Nettoliquiditeiten 2024 * | 3,01 mln. 3,85 mln. 3,54 mln. | EV/omzet 2024 * | 6,03 x |
K/w-verhouding 2023 |
-12,7
x | K/w-verhouding 2024 * |
-5,48
x | Werknemers | - |
Dividendrendement 2023 * |
-
| Dividendrendement 2024 * |
-
| Vrij verhandelbaar | 70,66% |
Recentste transcriptie over Avacta Group Plc
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Tony Gardiner
DFI | Director of Finance/CFO | 53 | 04-01-16 |
Matt Johnson
CTO | Chief Tech/Sci/R&D Officer | - | 16-09-13 |
Michael Vinegrad
IRO | Public Communications Contact | - | 01-06-14 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Trevor Nicholls
BRD | Director/Board Member | 67 | 02-08-13 |
Tony Gardiner
DFI | Director of Finance/CFO | 53 | 04-01-16 |
Paul Fry
BRD | Director/Board Member | 58 | 03-02-20 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+18,14% | 123 mld. | |
+14,78% | 107 mld. | |
-4,32% | 24,01 mld. | |
+2,18% | 22,59 mld. | |
-10,09% | 18,16 mld. | |
-41,04% | 16,84 mld. | |
-11,93% | 16,23 mld. | |
+2,63% | 13,43 mld. | |
+25,74% | 11,32 mld. |
- Beurs
- Aandelen
- Koers AVCT
- Koers